Renaissance Technologies’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.9M | Sell |
|
|||||
|
2025
Q1 | $81.5M | Sell |
|
|||||
|
2024
Q4 | $154M | Sell |
|
|||||
|
2024
Q3 | $146M | Sell |
|
|||||
|
2024
Q2 | $142M | Buy |
|
|||||
|
2024
Q1 | $109M | Buy |
|
|||||
|
2023
Q4 | $56.7M | Buy |
|
|||||
|
2023
Q3 | $41M | Sell |
|
|||||
|
2023
Q2 | $49.2M | Buy |
|
|||||
|
2023
Q1 | $57.8M | Buy |
|
|||||
|
2022
Q4 | $41.9M | Buy |
|
|||||
|
2022
Q3 | $35M | Buy |
|
|||||
|
2022
Q2 | $31.2M | Buy |
|
|||||
|
2022
Q1 | $24.3M | Buy |
|
|||||
|
2021
Q4 | $7.73M | Buy |
|
|||||
|
2021
Q3 | $349K | Sell |
|
|||||
|
2021
Q2 | $9.37M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $10.3M | Sell |
|
|||||
|
2020
Q2 | $50.4M | Buy |
|
|||||
|
2020
Q1 | $28.7M | Buy |
|
|||||
|
2019
Q4 | $21.9M | Sell |
|
|||||
|
2019
Q3 | $47.7M | Sell |
|
|||||
|
2019
Q2 | $90.3M | Buy |
|
|||||
|
2019
Q1 | $41.2M | Sell |
|
|||||
|
2018
Q4 | $107M | Buy |
|
|||||
|
2018
Q3 | $74.7M | Sell |
|
|||||
|
2018
Q2 | $98.2M | Buy |
|
|||||
|
2018
Q1 | $15.4M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $155M | Buy |
|
|||||
|
2016
Q4 | $78.5M | Buy |
|
|||||
|
2016
Q3 | $89.6M | Buy |
|
|||||
|
2016
Q2 | $69.7M | Buy |
|
|||||
|
2016
Q1 | $63.7M | Buy |
|
|||||
|
2015
Q4 | $35M | Sell |
|
|||||
|
2015
Q3 | $163M | Buy |
|
|||||
|
2015
Q2 | $123M | Buy |
|
|||||
|
2015
Q1 | $83.4M | Buy |
|
|||||
|
2014
Q4 | $55.5M | Buy |
|
|||||
|
2014
Q3 | $14.2M | Sell |
|
|||||
|
2014
Q2 | $26.5M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $11.7M | Buy |
|